{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:34:21Z","timestamp":1792899261509,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.neuropharm.2011.08.023","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T22:28:35Z","timestamp":1314829715000},"page":"1366-1378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method"],"prefix":"10.1016","volume":"61","author":[{"given":"Susan J.","family":"Bartko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Romberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Wess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Bussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Saksida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.08.023_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn992","article-title":"Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice","volume":"6","author":"Anagnostaras","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib3","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1523\/JNEUROSCI.5171-06.2007","article-title":"Perceptual functions of perirhinal cortex in rats: zero-delay object recognition and simultaneous oddity discriminations","volume":"27","author":"Bartko","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib4","unstructured":"Bartko, S.J., Winters, B.D., Wess, J., Mattson, M.P., Saksida, L.M., Bussey, T.J., 2008. The role of cholinergic muscarinic receptor subtypes in spontaneous object recognition and simultaneous oddity discrimination tasks. Annual Meeting of the Society for Neuroscience, Washington, D.C."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00213-010-2050-1","article-title":"A\u00a0computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil","volume":"214","author":"Bartko","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.neuropharm.2011.08.023_bib71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nprot.2008.41","article-title":"The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats","volume":"3","author":"Bari","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0306-4522(99)00065-2","article-title":"Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat","volume":"92","author":"Baunez","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1101\/lm.777308","article-title":"Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit","volume":"15","author":"Brigman","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1037\/0735-7044.111.5.920","article-title":"Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat","volume":"111","author":"Bussey","year":"1997","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1037\/0735-7044.115.4.957","article-title":"Discrimination of computer-graphic stimuli by mice: a method for the behavioral characterization of transgenic and gene-knockout models","volume":"115","author":"Bussey","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1101\/lm.987808","article-title":"The touchscreen cognitive testing method for rodents: how to get the best out of your rat","volume":"15","author":"Bussey","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1568007024606249","article-title":"Muscarinic receptors as a target for drugs treating schizophrenia","volume":"1","author":"Bymaster","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0166-4328(83)90138-9","article-title":"Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal","volume":"9","author":"Carli","year":"1983","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00213-004-1805-y","article-title":"Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia","volume":"174","author":"Chudasama","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2003.09.020","article-title":"Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity","volume":"146","author":"Chudasama","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1101\/lm.70904","article-title":"Cholinergic modulation of visual attention and working memory: dissociable effects of basal forebrain 192-IgG-saporin lesions and intraprefrontal infusions of scopolamine","volume":"11","author":"Chudasama","year":"2004","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-4328(89)80048-8","article-title":"Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal","volume":"33","author":"Cole","year":"1989","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","article-title":"Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib20","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1523\/JNEUROSCI.21-13-04908.2001","article-title":"Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task","volume":"21","author":"Dalley","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib21","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cercor\/bhh052","article-title":"Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex","volume":"14","author":"Dalley","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.npp.1300590","article-title":"Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance","volume":"30","author":"Dalley","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.npp.1301220","article-title":"Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine","volume":"32","author":"Dalley","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1152\/jn.00686.2010","article-title":"M1 and M4 receptors modulate hippocampal pyramidal neurons","volume":"105","author":"Dasari","year":"2011","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/1566524033479654","article-title":"Muscarinic receptors in schizophrenia","volume":"3","author":"Dean","year":"2003","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1367-5931(99)80063-5","article-title":"Muscarinic receptor ligands and their therapeutic potential","volume":"3","author":"Eglen","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib27","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/jm990607u","article-title":"Therapeutic opportunities for muscarinic receptors in the central nervous system","volume":"43","author":"Felder","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0896-6273(02)00587-1","article-title":"Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents","volume":"33","author":"Fisahn","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000113712","article-title":"M1 muscarinic agonists target major hallmarks of Alzheimer\u2019s disease \u2013 the pivotal role of brain M1 receptors","volume":"5","author":"Fisher","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib30","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1046\/j.1471-4159.1995.64041888.x","article-title":"Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer\u2019s disease","volume":"64","author":"Flynn","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/hipo.20059","article-title":"Hippocampal lesions that abolish spatial maze performance spare object recognition memory delays of up to 48 hours","volume":"15","author":"Forwood","year":"2005","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-004-1794-x","article-title":"Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists","volume":"174","author":"Friedman","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib33","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.96.22.12222","article-title":"Delineating muscarinic receptor functions","volume":"96","author":"Gainetdinov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib34","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1073\/pnas.261583798","article-title":"Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice","volume":"98","author":"Gerber","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.20-03-01208.2000","article-title":"Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex","volume":"20","author":"Granon","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-004-2127-9","article-title":"Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2\/3) receptor agonist LY379268","volume":"179","author":"Greco","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib37","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.1073\/pnas.94.24.13311","article-title":"Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice","volume":"94","author":"Hamilton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.npep.2005.01.001","article-title":"Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury","volume":"39","author":"Holmes","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib39","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1046\/j.1460-9568.1999.00701.x","article-title":"Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype","volume":"11","author":"Humby","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02246186","article-title":"Effect of scopolamine on visual attention in rats","volume":"120","author":"Jones","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib41","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/npp.2008.215","article-title":"Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to negative and executive\/cognitive symptoms of schizophrenia","volume":"34","author":"Karlsson","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib43","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/sj.npp.1300208","article-title":"Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia","volume":"28","author":"Le Pen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1460-9568.2003.02745.x","article-title":"A\u00a0double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and\/or the septal region","volume":"18","author":"Lehmann","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib45","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib46","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1523\/JNEUROSCI.22-05-01905.2002","article-title":"Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task","volume":"22","author":"McGaughy","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130050048","article-title":"The role of nicotinic and muscarinic acetylcholine receptors in attention","volume":"148","author":"Mirza","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib48","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1523\/JNEUROSCI.21-14-05239.2001","article-title":"Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor","volume":"21","author":"Miyakawa","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth1006-767","article-title":"Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system","volume":"3","author":"Morton","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00229886","article-title":"Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task","volume":"89","author":"Muir","year":"1992","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02245253","article-title":"Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron","volume":"118","author":"Muir","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cercor\/6.3.470","article-title":"The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task","volume":"6","author":"Muir","year":"1996","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib53","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1046\/j.1460-9568.2000.00183.x","article-title":"Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task","volume":"12","author":"Passetti","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib54","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1601-183X.2006.00284.x","article-title":"Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains","volume":"6","author":"Pattij","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/nlme.1996.0060","article-title":"Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder","volume":"66","author":"Puumala","year":"1996","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0306-4522(93)90409-9","article-title":"Stimulus-bound perseveration after frontal ablations in marmosets","volume":"52","author":"Ridley","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0301-0082(94)90039-6","article-title":"The psychology of perserverative and stereotyped behaviour","volume":"44","author":"Ridley","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0301-0511(96)05222-2","article-title":"Arousal systems and attentional processes","volume":"45","author":"Robbins","year":"1997","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib60","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1523\/JNEUROSCI.5242-10.2011","article-title":"Impaired attention in the 3xTgAD mouse model of Alzheimer\u2019s disease: rescure by donepezil (aricept)","volume":"31","author":"Romberg","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0028-3932(84)90098-8","article-title":"Varieties of perseveration","volume":"22","author":"Sandson","year":"1984","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib62","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0306-4522(99)00487-X","article-title":"Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents","volume":"95","author":"Sarter","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/14737175.9.1.73","article-title":"Role of the cholinergic system in the pathology and treatment of schizophrenia","volume":"9","author":"Scarr","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib64","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1017\/S1092852900014048","article-title":"Muscarinic agonists for the treatment of cognition in schizophrenia","volume":"13","author":"Sellin","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-009-1526-3","article-title":"A\u00a0novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease","volume":"205","author":"Talpos","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2011.08.023_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1523\/JNEUROSCI.14-01-00167.1994","article-title":"Basal forebrain lesions in monkeys disrupt attention but not learning and memory","volume":"14","author":"Voytko","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.pharmtox.44.101802.121622","article-title":"Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications","volume":"44","author":"Wess","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2009.10.002","article-title":"Muscimol, AP5, or scopolamine infused into perirhinal cortex impairs two-choice visual discrimination learning in rats","author":"Winters","year":"2010","journal-title":"Neurobiol. Learn. Mem"},{"key":"10.1016\/j.neuropharm.2011.08.023_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2008.12.020","article-title":"Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice","volume":"603","author":"Woolley","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.023_bib70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00702-004-0214-z","article-title":"CNS Targets for multi-functional drugs in the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"112","author":"Youdim","year":"2005","journal-title":"J.\u00a0Neural Transm."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081100356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081100356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:23:54Z","timestamp":1784910234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081100356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S002839081100356X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.023","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}